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Androgenetic alopecia (AGA), or male-pattern baldness, is the most common form of hair loss. Its pathogenesis is
androgen dependent, and genetic predisposition is the major requirement for the phenotype. We demonstrate that
genetic variability in the androgen receptor gene (AR) is the cardinal prerequisite for the development of early-
onset AGA, with an etiological fraction of 0.46. The investigation of a large number of genetic variants covering
the AR locus suggests that a polyglycine-encoding GGN repeat in exon 1 is a plausible candidate for conferring
the functional effect. The X-chromosomal location of AR stresses the importance of the maternal line in the
inheritance of AGA.
Androgenetic alopecia (AGA [MIM 109200]), or male-
pattern baldness, is characterized by a defined pattern
of hair loss from the scalp (Hamilton 1951). In whites,
the proportion of affected males increases steadily with
age, so that a male in his 50s has a 50% chance of having
some degree of AGA (Hamilton 1951). Association of
AGA with a variety of clinical phenotypes has been sug-
gested, including coronary heart disease (Lotufo et al.
2000), benign prostatic hyperplasia (Hawk et al. 2000),
prostate cancer (Oh et al. 1998), and disorders associ-
ated with insulin resistance (Matilainen et al. 2000). An-
drogen dependence is an important characteristic of
AGA, and genetic disposition, which is assumed to be
polygenic, plays the most substantial role in the devel-
Received March 21, 2005; accepted for publication April 27, 2005;
electronically published May 18, 2005.
Address for correspondence and reprints: Dr. Markus M. No¨then,
Department of Genomics, Life & Brain Center, University of Bonn,
Sigmund-Freud-Straße 25, 53127 Bonn, Germany. E-mail: markus
.noethen@uni-bonn.de
 2005 by The American Society of Human Genetics. All rights reserved.
0002-9297/2005/7701-0015$15.00
opment of AGA (Ku¨ster and Happle 1984; Ellis et al.
1998; Nyholt et al. 2003). Although the only factor
known to influence onset age in patients with AGA is
genetic predisposition, no systematic approach has hith-
erto been undertaken, to our knowledge, to identify the
contributing genes.
As part of a genomewide linkage study of AGA, we
investigated linkage to markers covering the X chro-
mosome. The sample consisted of 95 families in which
at least two brothers had early-onset AGA (391 geno-
typed individuals, including 201 affected men). We ob-
tained evidence of linkage in chromosomal region Xq12-
22 (nonparametric linkage [NPL] score of 2.70 [fig. 1])
(for X-chromosomal marker information, see table 1).
This region contains the AR gene (MIM 313700), which
is an obvious candidate for explaining the development
of AGA, and an association with this region has been
suggested elsewhere (Ellis et al. 2001), on the basis of
results from the investigation of three polymorphic sites.
In the present study, we have systematically explored the
contribution of the AR gene to the development of early-
onset AGA.
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Table 1
STR Markers Used for Linkage Analysis
of Chromosome X
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
We tested 39 SNPs, two STRs (a polyglutamine-en-
coding CAG repeat and a polyglycine-encoding GGN
repeat in exon 1 of AR), and one biallelic insertion poly-
morphism (XARx8insA), in a range of 4.4 Mb at the
AR locus, for association with AGA (fig. 2). Our analysis
included the three previously studied variants (Ellis et
al. 2001): the CAG and GGN repeats and StuI RFLP
(rs6152). TaqMan assays for genotyping of SNPs, listed
in table 2, were designed by Applied Biosystems. PCRs
were performed using 2.5 ng genomic DNA, AmpliTaq
Gold DNA polymerase (Applied Biosystems), and an
annealing temperature of 60C for 45 cycles on Biometra
T1 (Biometra) or Perkin Elmer GeneAmp 9700 (Applied
Biosystems) thermocyclers. Fluorescence was measured
with an ABI Prism 7900HT sequence detection system
(Applied Biosystems). The fragment lengths of the CAG
repeat, the GGN repeat, and XARx8insA were deter-
mined using the following fluorescence-labeled primers
for PCR: CAG-F 5′-TCCAGAATCTGTTCCAGAGCG-
TGC-3′ and CAG-R 5′-GCTGTGAAGGTTGCTGTTC-
CTCAT-3′ (La Spada et al. 1991), GGN-F 5′-CCTGGC-
ACACTCTCTTCACA-3′ and GGN-R 5′-GGATAGG-
GCACTCTGCTCAC-3′, and XARx8insA-F 5′-CACGG-
GAAGTTTAGAGAGCT-3′ and XARx8insA-R 5′-TCA-
CCTTCTCGTCACTATTG-3′. Forty nanograms of ge-
nomic DNA was used in PCRs with AmpliTaq DNA
polymerase (Applied Biosystems) in 38 cycles on a PTC-
200 (MJ Research). The annealing temperatures were
62C–60C (touchdown PCR) for the CAG repeat, 58C
for the GGN repeat, and 63C–55C (touchdown PCR)
for XARx8insA. MasterAmp PCR PreMix G (Epicentre)
was used to amplify GGN fragments. Fragment lengths
of the amplified products were analyzed on an ABI Prism
377 DNA sequencer (Applied Biosystems). Double-strand
sequencing of genomic regions was performed with the
ABI Prism BigDye Terminator Cycle Sequencing kit, ver-
sion 2.0 (Applied Biosystems), and the ABI Prism 3730
DNA analyzer (Applied Biosystems).
For case-control analysis, we compared allele frequen-
cies in 198 males with early-onset AGA (including 95
unrelated and randomly chosen affected individuals from
the linkage-analysis families), 188 control individuals, and
157 unaffected individuals. For family-based association
analysis, we studied 179 families containing at least one
affected male in the youngest generation. The family-
based association sample included the 95 families from
the linkage analysis and overlapped with the case sample,
for 179 individuals. All affected males were aged !40
years (mean [ SD] ) and had AGA that was32.0 5.2
representative of the most severely affected 10% of the
distribution for the respective age class, on the basis of
the classification of Hamilton (1951) (modified by Nor-
wood [1975]). AGA classification, age, and ethnicity were
the exclusive criteria used to select individuals for inclu-
sion in the case sample. Unaffected males were aged 160
years (mean ) and without AGA, representing67.9 6.2
the least-affected 20% of the distribution for this age class.
Families and unrelated individuals both with and without
AGA were recruited through various sources, including
press reports and advertisements in magazines, newspa-
pers, and placards. Control individuals were male blood
donors from the blood transfusion center of the University
Hospital Bonn, from whom information was available
only on sex, age in years (mean 29.4 8.6), and ethnicity.
EDTA anticoagulated venous blood samples were col-
lected from all individuals, and lymphocyte DNA was
isolated by salting out with saturated NaCl solution (Mil-
ler et al. 1988). All participants were of German descent.
The study was approved by the ethics committee of the
University of Bonn, and informed consent was obtained
from all participants.
Association analysis was conducted using a modifi-
cation of the FAMHAP software (Becker and Knapp
2004a, 2004b) for X-chromosomal data. Case-control
SNP single-marker analysis was performed using the x2
distribution of the contingency table, and mul-2# 2
tiallelic markers were evaluated with the permutational
version of the x2 test. For case-control haplotype anal-
ysis, P values were calculated from the x2 distribution
with n1 df of the respective likelihood-ratio test (np
number of different haplotypes). The family data were
analyzed with the permutation-based association test for
nuclear families (Zhao et al. 2000; Knapp and Becker
2003). For each marker (single-locus analysis) and each
marker combination (haplotype analysis), we used 1010
permutation replicates.
Pairwise distances between haplotypes were calculated
as allele mismatches. By resampling markers randomly
with replacement, 100 bootstrapped data sets were gen-
erated as input for the program neighbor contained in
the PHYLIP package.
A region of 1 Mb showed strong association with the
lowest P value of for rs10521339 in the122.1# 10
case-control analysis of affected and unaffected individ-
uals (table 3). As expected, the association is stronger
for comparisons between individuals with AGA and in-
dividuals without AGA than between individuals with
AGA and an unselected control sample (table 3). We
also performed a separate analysis of the 103 cases that
were not included in the linkage analysis and found that
the association was also present in this sample (data not
shown). The association is further supported by family-
based analysis, for which SNP rs938059 shows the low-
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Table 2
Oligonucleotides for TaqMan Assays
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Figure 2 Gene and LD structure of the AR locus. A, Distribution of known genes (left) and typed SNPs and STRs (right) at the AR locus.
The shown genomic region spans 4.4 Mb. Gene content information is based on Ensembl. B, LD in 198 individuals with AGA (upper right
diagonal) and in 157 individuals without AGA (lower left diagonal) was measured with x2 and was visualized using the GOLD program (Abecasis
and Cookson 2000).
est P value ( ) (table 3). AR is the only known64.03# 10
gene in the strongly associated 1-Mb–spanning region
(fig. 2 and table 3). The X-linked ectodysplasin-A2 re-
ceptor (XEDAR), which is located 900 kb 5′ of AR, is
outside this region (fig. 2 and table 3). The significance
of the association decreases within the 3′ part of the 180-
kb–spanning AR gene, and oligophrenin 1 (OPHN1),
which is located 320 kb 3′ of AR, is not within the block
of strongest association (fig. 2 and table 3). rs6152
( [table 3]) in exon 1 of AR corre-10Pp 6.66# 10
sponds to the StuI RFLP, for which an association has
been described by Ellis et al. (2001).
The long range of the associated SNPs implies the
presence of a large haplotype block, visible in fig. 2B.
In principle, this is not unexpected in a location close
to the centromere, where recombination events occur at
a relatively low frequency (Nagaraja et al. 1997). To test
whether the size of the haplotype block stands out even
in comparison with X-chromosomal loci with similar
low recombination frequencies, we analyzed average
pairwise linkage disequilibrium (LD) (measured by FD′F)
between SNPs retrieved from the HapMap Project da-
tabase in 1-cM–sized windows. Average pairwise LD
was found to be inversely correlated with recombination
rate (Spearman’s ; ). An average LDrp 0.598 P ! .001
higher than that at the AR locus was displayed by only
the six windows covering the centromere; these windows
showed distinctively smaller recombination rates (fig.
3A). This result might suggest that the predominant AR
haplotypes are evolutionarily more recent, perhaps in-
dicating positive selective pressure acting at this locus
(Bamshad and Wooding 2003). Since androgens mediate
a wide range of developmental and physiological re-
sponses through the androgen receptor (AR) and are
especially important in the male reproductive system
(Lee and Chang 2003), it is conceivable that variability
in AR can have an impact on selection. In accordance
with this hypothesis, the haplotype with the highest fre-
quency (0.45 [fig. 3B]) (which also confers risk of AGA)
in the German population seems to be evolutionarily
recent, as indicated by the low sequence identity with
the ancestral haplotype (fig. 3B).
Sequencing of the transcribed region and of 3.4 kb
of conserved sequences in the 5′ region and intron 1
of AR in 12 individuals revealed only two additional
variants of the associated haplotype (XARx7_01 and
XARx8insA [table 3]). The additional variants were
noncoding and did not show a stronger association than
other tested markers. Of the two repeat polymorphisms
in the coding region, the CAG repeat was not associated
with AGA (affected/unaffected global P value of .1),
whereas the GGN repeat was highly associated (affected/
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Table 3
Association of AGA with Markers at the AR Locus
SNP AND
ALLELE
FREQUENCY TDTa AFFECTED/CONTROL ANALYSIS AFFECTED/UNAFFECTED ANALYSIS
POSITIONbAffected Control Unaffected Transmitted Nontransmitted Pc P ORd CI P ORd CI
rs12560201: 6.68 # 101 8.99 # 101 1.04 .55–1.82 9.38 # 101 .97 .5–1.87 63,335,397
G .112 .108 .115 23 27
A .888 .892 .885
rs1332720: 1.00 1.00 ND ND 1.00 ND ND 64,598,557
C .995 1.000 1.000 0 1
T .005 .000 .000
rs1044165: 1.00 9.50 # 101 .98 .55–1.89 1.58 # 101 1.53 .85–2.76 65,024,747
A .124 .122 .178 22 23
G .876 .878 .822
rs708969: 5.35 # 101 1.21 # 102 2.02 1.16–3.53 3.90 # 103 2.27 1.29–4 65,252,916
A .875 .776 .755 36 29
T .125 .224 .245
rs1379146: 3.25 # 101 2.68 # 104 2.61 1.55–4.45 4.72 # 104 2.60 1.51–4.5 65,389,382
T .872 .723 .724 39 29
A .128 .277 .276
rs1158928: 1.30 # 101 1.04 # 105 3.23 1.89–5.56 2.08 # 105 3.22 1.85–5.61 65,532,217
A .883 .700 .701 42 27
G .117 .300 .299
rs1485682: 1.30 # 101 1.97 # 105 3.13 1.82–5.35 3.08 # 105 3.16 1.81–5.48 65,598,612
C .883 .707 .705 42 27
T .117 .293 .295
rs1385699: 1.22 # 101 1.60 # 105 3.23 1.86–5.59 9.41 # 105 3.00 1.71–5.32 65,608,007
A .887 .708 .722 44 28
G .113 .292 .278
rs1385695: 2.97 # 103 1.03 # 105 4.68 2.24–9.78 2.40 # 108 6.57 3.17–13.63 65,687,533
A .949 .799 .739 38 13
G .051 .201 .261
rs775362: 4.10 # 103 2.09 # 105 4.39 2.13–9.21 3.73 # 108 6.40 3.11–13.39 65,762,194
G .949 .809 .744 37 13
A .051 .191 .256
rs1041668: 1.49 # 104 1.80 # 106 6.42 2.74–15.03 1.58 # 109 9.29 4.03–21.44 65,868,977
G .036 .194 .258 9 39
A .964 .806 .742
rs5964577: 2.50 # 103 4.24 # 106 4.99 2.32–10.68 1.20 # 108 7.02 3.29–15.08 65,954,512
A .954 .806 .747 36 12
T .046 .194 .253
rs532649: 5.96 # 106 5.42 # 107 6.38 2.75–14.71 2.33 # 1010 9.62 4.17–22.13 66,050,269
A .960 .807 .735 37 7
G .036 .193 .265
rs989345: 4.65 # 106 1.60 # 106 6.24 2.74–14.66 6.13 # 1010 9.56 4.2–22.29 66,084,055
A .964 .811 .737 36 6
G .036 .189 .263
rs938059: 4.03 # 106 1.10 # 106 6.55 2.82–15.25 9.20 # 1010 9.63 4.18–22.17 66,119,748
C .036 .195 .263 7 40
A .964 .805 .737
rs925391: 4.76 # 106 5.97 # 107 7.28 3.03–18.03 1.98 # 1010 11.15 4.65–27.42 66,123,458
G .969 .811 .737 38 6
A .031 .189 .263
rs5919287: 4.62 # 106 2.57 # 107 6.61 2.87–12.82 1.76 # 1010 9.70 4.22–22.45 66,143,635
C .964 .802 .734 39 7
T .036 .198 .266
rs2221799: 4.62 # 106 3.37 # 107 6.53 2.84–15.18 1.39 # 109 9.21 4.04–21.47 66,159,637
A .964 .804 .744 39 7
G .036 .196 .256
rs10521339: 4.00 # 104 1.95 # 107 5.65 2.65–12.04 2.10 # 1012 9.89 4.62–20.7 66,291,407
A .954 .778 .677 11 41
T .046 .212 .323
rs2223841: 9.40 # 106 1.20 # 106 5.59 2.62–11.94 1.72 # 1011 9.48 4.48–20.05 66,353,192
A .954 .789 .688 44 11
G .046 .211 .312
rs2207081: 4.33 # 106 7.00 # 107 6.21 2.8–13.78 5.04 # 1012 10.72 4.89–23.75 66,356,719
A .959 .792 .688 44 10
G .041 .208 .312
rs2497935: 1.79 # 105 3.10 # 106 5.00 2.41–10.36 3.17 # 1011 8.69 4.23–17.87 66,447,287
A .949 .790 .684 45 12
G .041 .208 .316
rs962458: 2.89 # 103 2.87 # 104 7.32 2.12–25.3 2.56 # 106 11.10 3.27–37.74 66,528,985
G .015 .102 .146 2 17
A .985 .898 .854
CAGe: 2.71 # 101 f 66,548,181
18 .042 .085 .110 13 12 NS ND ND NS ND ND
19 .110 .106 .110 30 39 NS ND ND NS ND ND
20 .194 .112 .103 50 19 2.66 # 102 1.91 1.07–3.41 2.20 # 102 2.10 1.10–3.99
(continued)
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Table 3 (continued)
SNP AND
ALLELE
FREQUENCY TDTa AFFECTED/CONTROL ANALYSIS AFFECTED/UNAFFECTED ANALYSIS
POSITIONbAffected Control Unaffected Transmitted Nontransmitted Pc P ORd CI P ORd CI
21 .147 .191 .205 32 31 NS ND ND NS ND ND
22 .136 .122 .096 32 28 NS ND ND NS ND ND
23 .126 .090 .068 26 30 NS ND ND NS ND ND
24 .084 .080 .096 19 36 NS ND ND NS ND ND
25 .047 .064 .075 12 14 NS ND ND NS ND ND
rs6152: 5.88 # 105 3.80 # 106 5.26 2.45–11.3 6.66 # 1010 8.21 3.86–17.45 66,548,648
T .046 .201 .282 11 40
C .954 .799 .718
GGNe: 7.79 # 105 f 66,549,360
23 .651 .495 .421 76 43 2.06 # 103 1.91 1.26–.2.88 2.07 # 105 2.57 1.656–3.98
24 .182 .367 .461 21 68 5.39 # 105 .38 .24–.62 2.62 # 108 .26 .161–.42
rs1204038: 9.79 # 105 1.90 # 106 5.45 2.55–11.67 2.83 # 109 7.72 3.62–16.46 66,571,246
A .046 .208 .271 11 39
G .954 .792 .729
rs5919393: 1.58 # 105 6.00 # 107 5.82 2.73–12.41 1.69 # 108 7.88 3.7–16.77 66,608,378
C .046 .218 .274 11 38
T .954 .782 .726
rs1337080: 5.73 # 103 6.71 # 104 6.73 1.92–23.14 4.75 # 106 10.78 3.12–36.19 66,661,940
A .985 .907 .859 15 2
G .015 .093 .141
XARx7_001g: 1.00 6.79 # 102 3.95 .81–19.25 1.45 # 101 3.21 .61–16.76 66,725,646
A .010 .039 .032 3 3
G .990 .961 .968
XARx8insAh: 3.29 # 103 5.09 # 105 4.11 1.99–8.47 6.62 # 108 5.94 2.94–12.02 66,727,141
delA .944 .804 .739 34 13
A .056 .196 .261
rs2781516: 3.28 # 102 1.00 # 102 2.02 1.18–3.48 2.86 # 104 2.69 1.56–4.64 66,885,052
A .128 .228 .282 21 38
G .872 .772 .718
rs2885913: 4.46 # 102 1.49 # 104 2.31 1.49–3.57 4.29 # 105 2.53 1.62–3.97 66,898,824
G .255 .441 .465 40 64
A .745 .559 .535
rs2363785: 1.73 # 102 1.82 # 104 2.28 1.47–3.53 2.04 # 104 2.34 1.49–3.68 66,954,319
G .745 .562 .555 65 37
T .255 .438 .445
rs1936313: 2.48 # 102 7.91 # 105 2.37 1.54–3.64 9.15 # 104 2.15 1.36–3.37 66,983,669
T .744 .551 .575 65 39
C .256 .449 .425
rs492933: 2.44 # 102 1.15 # 102 1.76 1.13–2.72 2.39 # 102 1.69 1.07–2.65 67,046,865
C .736 .614 .623 67 40
T .264 .386 .377
rs1410127: 2.83 # 102 8.02 # 103 1.79 1.16–2.76 2.13 # 102 1.71 1.08–2.67 67,063,402
C .735 .608 .619 66 40
T .265 .392 .381
rs1157321: 7.83 # 104 1.59 # 105 2.89 1.75–4.7 2.73 # 105 2.93 1.75–4.87 67,104,762
G .848 .659 .656 64 27
T .152 .341 .344
rs7887862: 1.09 # 101 3.31 # 101 1.34 .74–2.41 1.28 # 101 1.65 .86–3.2 67,148,136
C .152 .118 .098 36 21
T .848 .882 .902
rs1927232: 6.77 # 101 1.77 # 101 1.36 .87–2.11 8.23 # 101 1.06 .66–1.69 67,165,912
C .719 .653 .708 49 44
T .281 .347 .292
rs5965536: 1.56 # 101 3.57 # 101 1.33 .73–2.41 9.50 # 101 1.02 .57–1.84 67,300,796
C .154 .121 .151 35 24
G .846 .879 .849
rs792952: 1.39 # 101 8.45 # 101 1.05 .65–1.69 8.56 # 101 1.05 .64–1.71 67,766,144
C .249 .240 .240 53 36
G .751 .760 .760
NOTE.—ND p not determined; NS p not significant.
a Family transmission/disequilibrium test (Knapp and Becker 2003).
b UCSC Genome Bioinformatics Plus Strand Build 35.
c Permutation-based value for association.
d Odds ratio.
e Only alleles with frequencies 0.05 in controls.
f Global P value.
g GCTTTGTCTAATGCTCCTTC[G/A]TGGGCATGCTTCCCCTCCCC(intron 6 of AR).
h ACAAGCAAACAAAAAAAAAA[A/delA]GCAAAAACAAAACAAAAAAT(exon 8 of AR).
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Figure 3 The AR locus: LD relative to the X-chromosome and haplotype structure. A, Average pairwise LD (measured by FD′F) between
SNPs retrieved from the HapMap Project database, plotted over X-chromosomal recombination rates in 1-cM–sized windows. An average LD
higher than that at the AR locus was displayed by only the six windows covering the centromere and showed distinctively smaller recombination
rates. B, Neighbor-joining tree of frequent haplotype sequences (15% in the samples from the individuals with AGA, controls, and individuals
without AGA) within the most strongly associated haplotype block (genetic markers rs1385695–XARx8insA). The CAG repeat, XARx7_01,
and XARx8insA were omitted from tree construction, because the corresponding Pan troglodytes allele could not be retrieved from the chimpanzee
genomic sequence. The AGA haplotype is shown in red, and the chimpanzee haplotype is shown in orange. The AGA haplotype shows low
sequence identity to the ancestral (chimpanzee) haplotype. Haplotype frequencies of the respective samples are indicated in parentheses (affected/
control/unaffected [in %]). GGN-23 is indicated as “23”; GGN-24 is indicated as “24.”
unaffected global P value of .0001). The study by Ellis
et al. (2001) also showed a larger effect for the GGN
repeat than the CAG repeat. However, the pooling of
alleles in their study renders an exact comparison of
results difficult. The GGN allele of 23 repeats showed
a difference of affected versus unaffected allele frequen-
cies of 0.23, which was in the range of the strongest-
associated SNPs (rs1385695–XARx8insA [table 3]) but
with a lower frequency in controls. This suggests that
GGN-23 either is closer to the AGA mutation or is itself
the AGA-susceptibility allele. Previously obtained func-
tional data, in which shorter repeat alleles of the GGN
repeat were associated with higher protein levels and
thereby higher AR activity (Ding et al. 2005), support
the possibility of a causal role for the repeat, and this
would be compatible with current understanding of the
involvement of androgens in AGA. Several studies have
also suggested an effect of CAG repeat lengths on AR
transactivating activity (Mhatre et al. 1993; Chamber-
lain et al. 1994; Kazemi-Esfarjani et al. 1995; Choong
et al. 1996; Nakajima et al. 1996; Beilin et al. 2000;
Ding et al. 2004). Since both repeats modulate AR ac-
tivity and since we observe an association only between
the GGN repeat and AGA, it may be that cells of the
hair follicle lack cofactors that interact with the CAG-
encoded domain.
Interestingly, shorter alleles for the GGN repeat have
also been associated with prostate cancer (Hsing et al.
2000; Chang et al. 2002), whereas longer alleles have
been associated with endometrial cancer (Sasaki et al.
2005), which would be in accordance with the differing
effects of androgens on the endometrium and the pros-
tate (androgens exert an inhibitory effect on endometrial
cell proliferation, whereas they have a mitogenic effect
in the prostate). However, the association findings with
prostate cancer remain controversial, and no effect was
shown in a large meta-analysis (Zeegers et al. 2004).
The association with endometrial cancer has yet to be
confirmed.
It remains possible that an as-yet-undetected variant
in either a regulatory region affecting the expression level
or an intronic variant affecting the splicing pattern of
AR might be responsible for AGA susceptibility. The
latter seems unlikely since we did not detect alternatively
spliced transcripts of AR in human hair follicles of seven
individuals representing different haplotypes. Previous
studies have identified AR regulatory elements up to po-
sition 737 of the AR transcription start site (Faber et
al. 1991, 1993; Supakar et al. 1993), as well as exonic
enhancers in exon 1 (Faber et al. 1993) and exons 4 and
5 (Grad et al. 2001). Our sequencing analysis of 12
individuals with the associated haplotype revealed no
variability in these regulatory elements of AR. However,
there may be additional regions with regulatory effect
that have not yet been fully characterized (Lower et al.
2004). Haplotypes carrying the GGN-24 allele show
clearly higher frequencies in individuals without AGA
than in those with AGA (fig. 3B). Since this effect is
strikingly weaker in the ACAAAAAGCATTTAAG-24-
ATA haplotype than in the other GGN-24–carrying hap-
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lotypes (fig. 3B), it is likely that further functionally rel-
evant variability exists that modifies the protective effect
of GGN-24–bearing haplotypes.
It is interesting to note that genetic variation in AR,
which is located on the X chromosome, cannot explain
the resemblance of fathers and sons with respect to the
development of AGA (Ku¨ster and Happle 1984; Ellis et
al. 1998), since sons always inherit the X chromosome
from their mothers. The fact that family studies of AGA
have typically stressed the resemblance of fathers and
sons is understandable, given the differences in patterns
of hair loss between males and females. Our genetic data,
however, stress the relative importance of the maternal
line in the inheritance of AGA, since we estimate an
etiological fraction of 0.46 that can be attributed to hav-
ing 23 GGN repeats within AR. This suggests that the
average phenotypic resemblance should be greater be-
tween affected males and their maternal grandfathers
than between affected males and their fathers. It is likely
that the remaining etiological fraction is due to genetic
variation at autosomal loci, which could explain the sim-
ilarity of the AGA pattern of fathers and sons. Some
autosomal candidate genes have been investigated in the
past, including the insulin gene (Ellis et al. 1999), the
5a-reductase genes (Ellis et al. 1998), and the hairless
gene (Hillmer et al. 2001, 2002), but none of these has
been associated with AGA. A systematic linkage-based
approach should enable the identification of additional
loci.
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